INTRODUCTION TO QUANTITATIVE BENEFIT-RISK ANALYSES METHODS
This course aims to give you an inclusive overview of the concept and scope benefit-risk evaluations of medicines, to inform you on the sources and integration of data for benefit-risk and at least to clarify the criteria for benefit-risk assessment model.
Qualitative & Quantitative B-R Measurement, Benefit-Risk Methodologies, European Medicines Agency
At the end of the course, you will be able to:
define benefit and risk in European Medicines Agency framework
explain the rationale of qualitative & quantitative B-R measurement in the process decision making
delect and integrate appropriate data sources for BR assessment
classify and group various Benefit-Risk methodologies.